MedTrace Logo

Mgso4 as Neuroprotective in Post Traumatic Brain Injury

NCT04646876 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-11-30

No results posted yet for this study

Summary

The aim of this study is to assess the potential role of magnesium sulphate (MgSo4) as a neuroprotective agent using the Glasgow outcome scale following moderate and severe traumatic brain injury.

Conditions

Interventions

DRUG

Magnesium Sulfate

Prospective , comparative , double blind study

DRUG

Placebo

Prospective , comparative , double blind study

Sponsors & Collaborators

  • Osama Mohamed Abdelwahab

    lead OTHER

Principal Investigators

  • Osama Awahab, professor · Faculty Of Medicine , Beni Suef University , Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2020-03-12
Completion
2020-06-02

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04646876 on ClinicalTrials.gov